June's AI-picked stock updates now live. See what's new in Tech Titans, up 28.5% year to date.See Full Update

CDC director Walensky recovers from COVID

Published 11/08/2022, 09:57 AM
Updated 11/08/2022, 04:41 PM
PFE
-

(Reuters) -The director of the U.S. Centers for Disease Control and Prevention, Rochelle Walensky, tweeted on Tuesday that she has recovered from COVID-19.

Walensky again tested positive for COVID with mild symptoms on Oct. 31 after completing a course of Pfizer (NYSE:PFE)'s Paxlovid, having contracted the infection on Oct. 22

© Reuters. FILE PHOTO: Dr. Rochelle Walensky, U.S. Centers for Disease Control and Prevention Director, testifies during a Senate Health, Education, Labor, and Pensions Committee hearing on the monkeypox outbreak, in Capitol Hill in Washington, U.S., September 14, 2022.

Walensky is the third senior government executive, after U.S. President Joe Biden and National Institute of Allergy and Infectious Diseases Director Dr Anthony Fauci to experience recurrent viral infection following the first course of Paxlovid.

Some people who took the antiviral drug have suffered from a relapse or a rebound soon after the five-day treatment course, studies have shown.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.